Free Trial

InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume

InMed Pharmaceuticals logo
$2.65 -0.03 (-1.12%)
As of 01:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

InMed Pharmaceuticals Short Interest Data

InMed Pharmaceuticals (INM) has a short interest of 215,700 shares, representing 18.13% of the float (the number of shares available for trading by the public). This marks a 555.62% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.63 million shares to cover all short positions.

Current Short Interest
215,700 shares
Previous Short Interest
32,900 shares
Change Vs. Previous Month
+555.62%
Dollar Volume Sold Short
$701.03 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
2,000,000 shares
Short Percent of Float
18.13%
Today's Trading Volume
25,131 shares
Average Trading Volume
1,634,265 shares
Today's Volume Vs. Average
2%
Short Selling InMed Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INM Short Interest Over Time

INM Days to Cover Over Time

INM Percentage of Float Shorted Over Time

InMed Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2025215,700 shares $701.03 thousand +555.6%18.1%0.1 $3.25
6/15/202532,900 shares $83.24 thousand -33.7%2.8%0 $2.53
5/31/202549,600 shares $122.51 thousand -46.0%7.0%0 $2.47
5/15/202591,900 shares $270.19 thousand +191.8%12.9%1 $2.94
4/30/202531,500 shares $93.87 thousand -27.6%N/A0.8 $2.98
4/15/202543,500 shares $120.93 thousand +58.2%6.1%0.8 $2.78
3/31/202527,500 shares $56.93 thousand +26.7%3.9%0.1 $2.07
3/15/202521,700 shares $61.19 thousand -19.3%3.1%0 $2.82
2/28/202526,900 shares $79.09 thousand -25.1%3.8%0.1 $2.94
2/15/202535,900 shares $113.44 thousand +8.5%5.0%0.1 $3.16
1/31/202533,100 shares $101.95 thousand +1,125.9%N/A0.1 $3.08
1/15/20252,700 shares $11.72 thousand -71.0%N/A0 $4.34
12/31/20249,300 shares $44.08 thousand -30.1%N/A0.2 $4.74
12/15/202413,300 shares $69.96 thousand +3.9%N/A0.3 $5.26
11/30/202412,800 shares $54.91 thousand -50.6%N/A0.3 $4.29
11/15/202425,900 shares $110.85 thousand -77.6%N/A0.5 $4.28
10/31/2024115,500 shares $30.71 thousand +188.8%N/A0 $0.27
10/15/202440,000 shares $8.76 thousand -57.1%N/A0 $0.22
9/30/202493,200 shares $22.09 thousand -82.6%N/A0 $0.24
9/15/2024534,900 shares $139.82 thousand +55.3%N/A0.1 $0.26
8/31/2024344,500 shares $122.26 thousand +818.7%N/A0 $0.35
8/15/202437,500 shares $5.40 thousand -85.2%N/A0 $0.14
7/31/2024253,200 shares $44.51 thousand +85.2%N/A0.2 $0.18
7/15/2024136,700 shares $36.46 thousand +61.4%N/A0.1 $0.27
6/30/202484,700 shares $22.49 thousand -43.5%N/A0.1 $0.27
6/15/2024150,000 shares $34.01 thousand +252.9%N/A0.2 $0.23
5/31/202442,500 shares $12.54 thousand -44.6%N/A0.1 $0.30
5/15/202476,700 shares $21.02 thousand -78.6%N/A0.2 $0.27
4/30/2024359,000 shares $96.57 thousand +213.5%N/A0.9 $0.27
4/15/2024114,500 shares $36.49 thousand +1,011.7%N/A0.3 $0.32
3/31/202410,300 shares $3.75 thousand -81.9%N/A0 $0.36
3/15/202457,000 shares $20.52 thousand -13.9%N/A0.3 $0.36
2/29/202466,200 shares $27.47 thousand -52.1%N/A0.3 $0.42
2/15/2024138,300 shares $47.99 thousand +244.9%N/A0.7 $0.35
1/31/202440,100 shares $14.43 thousand -43.4%N/A0.2 $0.36
1/15/202470,800 shares $27.08 thousand -47.2%N/A0 $0.38
12/31/2023134,000 shares $55.74 thousand +1,213.7%N/A0.1 $0.42
12/15/202310,200 shares $3.67 thousand -65.9%N/A0 $0.36
11/30/202329,900 shares $13.16 thousand +510.2%N/A0 $0.44
11/15/20234,900 shares $1.99 thousand -74.1%N/A0 $0.41
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
10/31/202318,900 shares $9.14 thousand +339.5%N/A0 $0.48
10/15/20234,300 shares $2.74 thousand +377.8%N/A0 $0.64
9/30/2023900 shares $629.91 -90.1%N/A0 $0.70
9/15/20239,100 shares $7.68 thousand -65.4%N/A0.2 $0.84
8/31/202326,300 shares $21.59 thousand +64.4%N/A0.5 $0.82
8/15/202316,000 shares $14.96 thousand -61.5%N/A0.2 $0.94
7/31/202341,500 shares $46.48 thousand +112.8%N/A0.5 $1.12
7/15/202319,500 shares $18.72 thousand +2.6%N/A0.2 $0.96
6/30/202319,000 shares $17.48 thousand -63.2%N/A0.2 $0.92
6/15/202351,600 shares $65.53 thousand +4.7%N/A0.4 $1.27
5/31/202349,300 shares $66.06 thousand -24.0%N/A0.1 $1.34
5/15/202364,900 shares $75.28 thousand -30.8%N/A0.1 $1.16
4/30/202393,800 shares $112.56 thousand -25.7%N/A0.2 $1.20
4/15/2023126,300 shares $157.88 thousand +3.8%N/A0.2 $1.25
3/31/2023121,700 shares $131.44 thousand -27.7%N/A0.2 $1.08
3/15/2023168,400 shares $178.50 thousand +194.9%N/A0.2 $1.06
2/28/202357,100 shares $75.94 thousand -15.8%N/A0.1 $1.33
2/15/202367,800 shares $113.23 thousand -7.6%N/A0.1 $1.67
1/31/202373,400 shares $135.06 thousand -75.4%N/A0.1 $1.84
1/15/2023297,800 shares $562.84 thousand +443.4%3.8%0.3 $1.89
12/30/202254,800 shares $110.70 thousand +13.0%0.7%0.1 $2.02
12/15/202248,500 shares $90.21 thousand +62.8%0.6%0.1 $1.86
11/30/202229,800 shares $78.97 thousand +223.9%0.4%0 $2.65
11/15/20229,200 shares $25.58 thousand -32.9%0.1%0 $2.78
10/31/202213,700 shares $41.79 thousand +121.0%0.2%0 $3.05
10/15/20226,200 shares $32.92 thousand -83.9%0.1%0 $5.31
9/30/202238,600 shares $254.52 thousand -57.3%0.5%0 $6.59
9/15/202290,300 shares $867.78 thousand +12,800.0%1.2%0.1 $9.61
8/31/2022700 shares $4.17 thousand -89.4%N/A0 $5.95
8/15/20226,600 shares $2.57 thousand -62.5%0.1%0 $0.39
7/31/202217,600 shares $6.86 thousand -18.9%0.2%0.1 $0.39
7/15/202221,700 shares $8.03 thousand +6.4%0.3%0.1 $0.37
6/30/202220,400 shares $9.60 thousand -80.1%0.3%0.1 $0.47
6/15/2022102,300 shares $53.40 thousand +47.6%1.3%0.5 $0.52
5/31/202269,300 shares $53.36 thousand -29.4%0.9%0.3 $0.77
5/15/202298,100 shares $81.42 thousand -34.3%1.3%0.5 $0.83
4/30/2022149,300 shares $135.86 thousand -8.7%1.9%0.7 $0.91
4/15/2022163,600 shares $142.81 thousand +34.1%2.1%0.8 $0.87
3/31/2022122,000 shares $115.01 thousand +114.4%1.6%0.9 $0.94
3/15/202256,900 shares $41.02 thousand -35.3%0.7%0.6 $0.72
2/28/202287,900 shares $82.82 thousand +2.6%1.1%0.8 $0.94
2/15/202285,700 shares $99.41 thousand -2.7%1.1%0.3 $1.16
1/31/202288,100 shares $106.60 thousand -15.7%1.1%0 $1.21
1/15/2022104,500 shares $129.58 thousand +74.5%1.3%0 $1.24
12/31/202159,900 shares $78.47 thousand -8.4%0.8%0 $1.31
12/15/202165,400 shares $96.79 thousand -56.5%0.8%0 $1.48
11/30/2021150,400 shares $285.76 thousand +69.9%1.9%0.1 $1.90
11/15/202188,500 shares $118.59 thousand -19.7%1.1%0 $1.34
10/29/2021110,200 shares $168.06 thousand +69.3%1.4%0.2 $1.53
10/15/202165,100 shares $91.14 thousand -2.5%0.8%0.1 $1.40
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
9/30/202166,800 shares $116.90 thousand +189.2%0.8%0.3 $1.75
9/15/202123,100 shares $47.55 thousand +216.4%0.3%0.2 $2.06
8/31/20217,300 shares $16.13 thousand -92.4%0.1%0.1 $2.21
8/13/202196,600 shares $231.84 thousand -47.8%1.2%1.4 $2.40
7/30/2021185,100 shares $516.43 thousand +98.2%2.3%2.6 $2.79
7/15/202193,400 shares $249.38 thousand +396.8%1.2%1.3 $2.67
6/30/202118,800 shares $59.78 thousand +37.2%0.2%0.2 $3.18
6/15/202113,700 shares $39.05 thousand -2.8%0.2%0.2 $2.85
5/28/202114,100 shares $41.60 thousand +30.6%0.2%0.2 $2.95
5/14/202110,800 shares $30.35 thousand -90.7%0.1%0.1 $2.81
4/30/2021115,800 shares $431.93 thousand -14.7%1.5%0.7 $3.73
4/15/2021135,800 shares $435.92 thousand -64.8%1.7%0.7 $3.21
3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13
3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75
2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37
2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35
1/29/2021138,400 shares $546.69 thousand +63.2%2.0%0.6 $3.95
1/15/202184,800 shares $367.18 thousand No Change1.2%0.7 $4.33

INM Short Interest - Frequently Asked Questions

What is InMed Pharmaceuticals' current short interest?

Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 215,700 shares of INM short. 18.13% of InMed Pharmaceuticals' shares are currently sold short. Learn More on InMed Pharmaceuticals' current short interest.

What is a good short interest percentage for InMed Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.13% of InMed Pharmaceuticals' floating shares are currently sold short.

Is InMed Pharmaceuticals' short interest increasing or decreasing?

InMed Pharmaceuticals saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 215,700 shares, an increase of 555.6% from the previous total of 32,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does InMed Pharmaceuticals' short interest compare to its competitors?

18.13% of InMed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Chemomab Therapeutics Ltd. Sponsored ADR (0.94%), Aytu BioPharma Inc. (9.12%), Cyclacel Pharmaceuticals, Inc. (0.08%), BioAtla, Inc. (7.99%), Synlogic, Inc. (0.53%), Finch Therapeutics Group, Inc. (0.01%), Sonnet BioTherapeutics Holdings, Inc. (1.32%), MARKER THERAPEUTICS, INC. (1.55%), Reviva Pharmaceuticals Holdings, Inc. (10.24%), Relmada Therapeutics, Inc. (2.26%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short InMed Pharmaceuticals stock?

Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against InMed Pharmaceuticals?

A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further.

How often is InMed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:INM) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners